The DOI matches its Crossref record; 23 of the 28 references it cites were found in a registry or an index.
Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer
Open accessAbstract
Importance: Adjuvant chemotherapy in patients with stage III colon cancer prevents recurrence by eradicating minimal residual disease. However, which patients remain at high risk of recurrence after completing standard adjuvant treatment cannot currently be determined. Postsurgical circulating tumor DNA (ctDNA) analysis can detect minimal residual disease and is associated with recurrence in colorectal cancers. Objective: To determine whether serial postsurgical and postchemotherapy ctDNA analysis could provide a real-time indication of adjuvant therapy efficacy in stage III colon cancer. Design, Setting, and Participants: This multicenter, Australian, population-based cohort biomarker study recruited 100 consecutive patients with newly diagnosed stage III colon cancer planned for 24 weeks of adjuvant chemotherapy from November 1, 2014, through May 31, 2017. Patients with another malignant neoplasm diagnosed within the last 3 years were excluded. Median duration of follow-up was 28.9 months (range, 11.6-46.4 months). Physicians were blinded to ctDNA results. Data were analyzed from December 10, 2018, through June 23, 2019. Exposures: Serial plasma samples were collected after surgery and after chemotherapy. Somatic mutations in individual patients' tumors were identified via massively parallel sequencing of 15 genes commonly mutated in colorectal cancer. Personalized assays were designed to quantify ctDNA. Main Outcomes and Measures: Detection of ctDNA and recurrence-free interval (RFI). Results: After 4 exclusions, 96 eligible patients were eligible; median patient age was 64 years (range, 26-82 years); 49 (51%) were men. At least 1 somatic mutation was identified in the tumor tissue of all 96 evaluable patients. Circulating tumor DNA was detectable in 20 of 96 (21%) postsurgical samples and was associated with inferior recurrence-free survival (hazard ratio [HR], 3.8; 95% CI, 2.4-21.0; P < .001). Circulating tumor DNA was detectable in 15 of 88 (17%) postchemotherapy samples. The estimated 3-year RFI was 30% when ctDNA was detectable after chemotherapy and 77% when ctDNA was undetectable (HR, 6.8; 95% CI, 11.0-157.0; P < .001). Postsurgical ctDNA status remained independently associated with RFI after adjusting for known clinicopathologic risk factors (HR, 7.5; 95% CI, 3.5-16.1; P < .001). Conclusions and Relevance: Results suggest that ctDNA analysis after surgery is a promising prognostic marker in stage III colon cancer. Postchemotherapy ctDNA analysis may define a patient subset that remains at high risk of recurrence despite completing standard adjuvant treatment. This high-risk population presents a unique opportunity to explore additional therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a growing body of data demonstrating numerous clinical applications for ctDNA in adults with solid tumors, ranging from prognostication and evaluation of minimal residual disease (MRD) to detection of targetable alterations.7–12”
From Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study (2026) · cites this paper as [11]
In the citing paper
“A salient example of the well-established relationship between ctDNA burden and disease status in adult solid tumors is the use of ctDNA for MRD detection and monitoring for recurrence in colorectal cancers.10–12”
From Clinical Liquid Biopsy Testing for Detection of Actionable Genomic Alterations in Children and Young Adults With Advanced Solid Tumors on the GAIN Study (2026) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Self-citationOxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J. M., Hickish, T., Topham, C., Zaninelli, M., Clingan, P. R., Bridgewater, J. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,694
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746
Self-citationLevamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
Moertel, C. G., Fleming, T. R., Macdonald, J. S., Haller, D. G., Laurie, J. A., Goodman, P. J., Ungerleider, J. S., Emerson, W. A., Tormey, D. C., Glick, J. H., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002083220602 · Cited by 2,261
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220
Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6219 · Cited by 1,492
Self-citationMutation tracking in circulating tumor DNA predicts relapse in early breast cancer
García-Murillas, I., Schiavon, G., Weigelt, B., Ng, C. K. Y., Hrebien, S., Cutts, R. J., Cheang, M. C. U., Osin, P., Nerurkar, A. Y., Kozarewa, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0021 · Cited by 1,174
Detection and quantification of rare mutations with massively parallel sequencing
Kinde, I., Wu, J., Papadopoulos, N., Kinzler, K. W., & Vogelstein, B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105422108 · Cited by 1,144
Self-citationChaudhuri, A. A., Chabon, J. J., Lovejoy, A. F., Newman, A. M., Stehr, H., Azad, T. D., Khodadoust, M. S., Esfahani, M. S., Liu, C. L., Zhou, L., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0716 · Cited by 1,105
Research works printed but not linked: 1
- Song, 2008, A semiparametric approach for the covariate specific ROC curve with survival outcome., Stat Sin, 947
Cited by
Sorted by citations
Items 601–690 of 690
Liu, Z., Lu, T., Li, J., Wang, L., Xu, K., Dang, Q., Guo, C., Liu, L., 焦德超, Sun, Z., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14927048
Yuan, Y., Xiao, W., Xie, W.-H., 蔡培强, 王俏镟, Chang, H., Chen, B.-Q., Zhou, W.-H., Zhifan, Z., Wu, X.-J., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14068044
Self-citationTo, Y. H., Gibbs, P., Tie, J., IJzerman, M., & Degeling, K. (2023) · Figshare · doi:10.6084/m9.figshare.22610875
Self-citationYuan, Z., Chen, W., Liu, D., Qin, Q., Grady, W. M., Fichera, A., Wang, H., Hou, T., Lv, X., Li, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26583333
Casas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.27078882
Chen, G., Peng, J., Xiao, Q., Wu, H.-X., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608838
Self-citationChen, G., Peng, J., Xiao, Q., Wu, H.-X., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608862
Self-citationCasas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.27078894
Yang, H., Xiao, X., Zeng, L., Zeng, H., Zheng, Y., Wang, J., Li, G., Dai, W., He, Y., Wang, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25139606
Casas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.27078891
Casas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.27078897
Gao, Z., Huang, D., Chen, H., Yang, Y., An, K., Ding, C., Yuan, Z., Zhai, Z., Niu, P., Gao, Q., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22611845
Self-citationChen, G., Peng, J., Xiao, Q., Wu, H.-X., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608841
Self-citationChen, G., Peng, J., Xiao, Q., Wu, H.-X., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608859
Self-citationChen, G., Peng, J., Xiao, Q., Wu, H.-X., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608856
Self-citationYang, Y., Lu, Y., Tan, H. S., Bai, M., Wang, X., Ge, S., Ning, T., Zhang, L., Duan, J., Sun, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22792680
Casas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.27078918
Casas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27078906
Casas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.27078879
Casas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.27078915
Chen, G., Peng, J., Xiao, Q., Wu, H.-X., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608847
Self-citationCasas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.27078903
Yuan, Z., Chen, W., Liu, D., Qin, Q., Grady, W. M., Fichera, A., Wang, H., Hou, T., Lv, X., Li, C., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26583330
Chen, G., Peng, J., Xiao, Q., Wu, H.-X., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608865
Self-citationXue, W., Qiu, K., Dong, B., Guo, D., Fu, J., Zhu, C., & 牛兆健 (2023) · Figshare · doi:10.6084/m9.figshare.24209135
Chen, G., Peng, J., Xiao, Q., Wu, H.-X., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608832
Self-citationCasas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.27078900
Chen, G., Peng, J., Xiao, Q., Wu, H.-X., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608835
Self-citationChen, G., Peng, J., Xiao, Q., Wu, H.-X., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608844
Self-citationChen, G., Peng, J., Xiao, Q., Wu, H.-X., Wu, X., Wang, F., Li, L., Ding, P., Zhao, Q., Li, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14608868
Self-citationCasas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.27078888
Casas-Arozamena, C., Vilar, A., Cueva, J. F., Arias, E., Sampayo, V., Díaz, E., Oltra, S. S., Moiola, C. P., Cabrera, S., Cortegoso, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.27078909
Genomic Biomarkers to Guide the Management of Spine Metastases
Cederquist, G., & Schmitt, A. M. (2025) · Springer eBooks · doi:10.1007/978-3-032-07519-2_13
Li, P., li, T., Huang, M., Liu, P., Liu, P., Wu, Y., Li, X., He, R., Gan, Y., Hong, Y., et al. (2026) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-025-06407-3
Cushman, C. J., Coffin, M. L., Archer, T., Nazim, M., & Elfedaly, M. (2026) · Cureus · doi:10.7759/cureus.101382
Li, D., Zhao, Z., Wei, G., Qiu, W., Lin, Z., He, J., Li, B., Wang, J., Zheng, L., Feng, F., et al. (2026) · Open Research (University of Surrey) · doi:10.1002/viw.20250131
Minimally Invasive/Robotic Surgery for Colon Cancer
Alvarez, C., & Rashidi, L. (2026) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2025.12.002
Bozyiğit, C., Altintas, R., Çeçen, E., Beyaz, S., Çetkin, T., Koçyiğit, F. B., Arkalı, G., Varolgüneş, G. V. Y., & Ekinci, İ. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3997
Biología molecular del cáncer colorrectal
García‐Foncillas, J., Jiménez, P., Ávila-Rodríguez, V., Macías, S. I. G., Manrique, M. E., Rendón-Hernández, J., Angarita, J. M., Calvo, J. F., & Bonilla, C. E. (2026) · Revista Colombiana de Hematología y Oncología · doi:10.51643/22562915.853
Angelis, M. T. D., Santamaria, G., Amaddeo, A., Iannello, A. M., Viglietto, G., & Rizzuto, A. (2026) · Surgical Oncology · doi:10.1016/j.suronc.2026.102382
Endpoint Governance and Reporting Transparency in Biomarker-Guided Oncology Trials
Nwachukwu, F., & Obimma, M. C. (2026) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000001320
Colorectal cancer in elderly patients: a literature review
Алиев, И. И., Ivlev, D. A., Kazantsev, A. I., & Moiseenko, V. M. (2026) · Russian surgical journal · doi:10.18705/3034-7270-2026-2-1-56-66
田中, 敬. (n.d.) · Institutional Repositories DataBase (IRDB)
Lin, Y., Oroperv, C., Frydendahl, A., Rasmussen, M. H., Andersen, C. L., & Besenbacher, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.30.714025
黎, 飞. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1641308
Wang, E., Sasaki, M., Nagashima, D., Fujiwara, Y., & Tokuhara, T. (2026) · Journal of Clinical Question · doi:10.69854/jcq.2026.0009
Pan, S., & Wang, G. (2026) · Surgical Endoscopy · doi:10.1007/s00464-026-12784-8
Circulating Tumor DNA for Minimal Residual Disease in Colon Cancer: Ready for Prime Time?
Wu, Y. L., & Manji, G. A. (2026) · Journal of Clinical Oncology · doi:10.1200/jco-26-00369
Miyahara, S., Takahashi, H., Tomimaru, Y., Kobayashi, S., Tahara, S., Sasaki, K., Hasegawa, S., Iwagami, Y., Yamada, D., Akita, H., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-48779-7
Wada, Y., Nishi, M., Noma, T., Tokunaga, T., Kashihara, H., Takasu, C., Yoshimoto, T., & Shimada, M. (2026) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000004253
Circulating tumour DNA in colorectal cancer: current and emerging clinical applications
O’Rourke, H., & Tie, J. (2026) · Academia oncology. · doi:10.20935/acadonco8279
Self-citationWang, J., Ni, X., Zheng, Y., Wang, S., Bao, H., Fan, K., Shen, S., Zhu, D., Xie, Q., Bao, H., et al. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00468-7
Huang, Q., Tao, M., Zou, H., & Zheng, L. (2026) · Springer eBooks · doi:10.1007/978-981-97-1574-9_16-1
Zhou, S.-Q., & Ke, Q.-H. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.118773
Losada, J., Lasarte, A. S., & López, I. A. L. (2026) · Educación Médica · doi:10.1016/j.edumed.2026.101205
THE ROLE OF LIQUID BIOPSY IN THE DIAGNOSIS OF ENDOMETRIAL CANCER: A BIBLIOMETRIC ANALYSIS
Gyriavenko, N., Moskalenko, R., & Kiptenko, L. I. (2026) · Eastern Ukrainian Medical Journal · doi:10.21272/eumj.2026;14(2);338-347
Ofori, K. A., & Turaga, K. K. (2026) · Annals of Surgical Oncology · doi:10.1245/s10434-026-20076-7
Xu, Y., Cheng, Q., & Yang, H. U. I. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1846793
Current status of circulating tumor DNA application in colorectal cancer
Aitkulova, A. M., Kadenova, T., Gabdulkayum, A., Yerezhepov, D., Рахимова, С. Е., Samatkyzy, D., Begimbetova, D., Kozhamkulov, U. A., Akilzhanova, A., & Sarbassov, D. D. (2026) · Medicine and ecology · doi:10.59598/me-2305-6053-2026-118-1-58-67
Quinn, K. M., Hulse, J. C., Oberholtzer, N. P., Mattila, C., Hill, E., & Donahue, C. (2026) · Surgical Oncology Insight · doi:10.1016/j.soi.2026.100272
Xiang-mao, Z., Zeng, Z.-Y., Liu, B.-G., Yin, N., & Qu, H.-B. (2026) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.119305
Koo, T. H., Chowdhary, R., Arora, K., Lai, K. C. L., & Zakaria, A. D. (2026) · Biomedicines · doi:10.3390/biomedicines14081674
Guo, X.-X., Deng, J.-Z., Cheng, L.-Q., Lin, Y.-B., Cao, T., Feng, J.-L., Gao, Y.-N., Yang, X.-S., & Liang, S.-S. (2026) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.120399
이재임, Jeon, Y., Baek, J., Kang, S. I., Kim, S., Jeong, W. K., Yang, I. J., Kim, J. Y., & Lee, K. H. (2026) · Research Square · doi:10.21203/rs.3.rs-10287393/v1
Sharma, A., Tan, J. K., Kumar, H., Dhali, A., Paladiya, R., Sisodia, R., Bharadwaj, H. R., Dahiya, D. S., & Mandal, S. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1894198
de Nóbrega, M., Kaorey, N., Godoy, L. R., Dickinson, K., Wu, D., Tanchingco, A., Agnihotram, R. V., & Burnier, J. V. (2026) · The Journal of Liquid Biopsy · doi:10.1016/j.jlb.2026.100487
Clark, M., Prathapam, R., Bramlett, K. S., Helfrich-Kröger, A., Sussman, R. T., Hwang, H. J., Querfurth, R., Champion, K. J., Holtrup, F., Slavin, T. P., et al. (2026) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2026.07.006
Self-citationBeyond tissue biopsy: ctDNA methylation analysis for prediction of colorectal cancer prognosis
Irie, T., & Sugimoto, K. (2026) · Epigenomics · doi:10.1080/17501911.2026.2719145
Kandula, P. R., Maheswaran, H., & Pitchaimuthu, M. (2026) · Surgeries · doi:10.3390/surgeries7030101
Tissue-Informed ctDNA Assay Performance in Head and Neck Squamous Cell Carcinoma
Sicard, R. M., Cooke, P. V., Steinbaum, A., Shaari, D., Yang, A. B., Gomez, E., Kraft, D. O., Berger, M., Teng, M. S., Khan, M. N., et al. (2026) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2026.2469
Li, Y., Zhang, X., Luo, B., Lin, S., Zhao, R., Peng, L., Kang, J., & Changlin, Z. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7394170
Denost, Q., Rouanet, P., Teruel, E., Borg, C., Lelong, B., Etienne, P.-L., Maingon, P., Rio, E., Tuech, J., Noiret, B., et al. (2026) · European Journal of Cancer · doi:10.1016/j.ejca.2026.117046
Marsoni, S., Montagut, C., Pietrantonio, F., Bianchi, A. S., Lazzari, L., Bergamo, F., Zampino, M. G., Tarazona, N., Mandalà, M., Tamberi, S., et al. (2026) · Nature Cancer · doi:10.1038/s43018-026-01237-9
Al-Shamsi, H. O., Rafii, S., Tirmazy, S. H., Mukherji, D., Abuhelwa, A. Y., Iqbal, F., Abdelwahab, S. İ., Kourié, H. R., & Abdelrahim, M. (2026) · OncoTargets and Therapy · doi:10.2147/ott.s619488
Raftery, N. B., Ward, M. P., Donohoe, C. L., Lowery, M., & Elliott, J. A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15197389
Yalav, O., Yildirim, A., Guliyeva, N., Aydın, İ., Gümüş, S., Topal, U., Eray, İ. C., & Parsak, C. K. (2026) · Medicina · doi:10.3390/medicina62101865
Negru, T., Stana, L. G., Stanga, L., Dejeu, D., Ilie, A. C., & Pantea, Ș. (2026) · Medical Sciences · doi:10.3390/medsci14060632
Hyde, H., Mageau, E., Leduc, C. M., Madhu, M. J., Dickinson, N., Nisa, T.-U., Czajka, K. M., Santi, S. A., Jani, P., Wai, G., et al. (2026) · Current Oncology · doi:10.3390/curroncol33100606
Ekpunobi, N. F., Kyere, M., Oghonyon, E. I., Abimbola, J. O., & Agu, K. C. (2026) · Magna Scientia Advanced Biology and Pharmacy · doi:10.30574/msabp.2026.19.1.0078
Masood, A., Aamir, Z., Khurram, A., Tariq, H., Shaukat, A. F., Mujeeb, A., & Akilimali, A. (2026) · Thrombosis Journal · doi:10.1186/s12959-026-00936-8
Zhao, Q., Wu, C., Huang, X., Yang, M., & Zhang, B. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1928945
Singh, J., Kumar, M., & Kamra, K. (2026) · Interdisciplinary medicine · doi:10.1002/inmd.70179
Tejas, S. V., & Anusha, S. M. (2026) · Indian Journal of Gynecologic Oncology · doi:10.1007/s40944-026-01152-y
Guo, D., Zhang, S.-Y., Zhang, X., Lin, X., Aye, L., Liu, H.-C., Wang, X.-Y., Gu, Z., Fu, X.-T., Yang, G.-H., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218880
S3-Leitlinie Kolorektales Karzinom
Pox, C. P., Reichermeier, S., Aretz, S., Graeven, U., Hüneburg, R., Hüppe, D., Koch, C., Köhne, C.-H., Kolligs, F. T., Ludwig, L., et al. (2026) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2853-0320
Attitudes of cancer patients toward ctDNA ‐based liquid biopsy for follow‐up
Chhajlani, S., Mariën, L., Weerdt, C. D., Wouters, S., Teuwen, L.-A. M. N., Prenen, H., Janssens, K., & Vandamme, T. (2026) · Molecular Oncology · doi:10.1002/1878-0261.70352
Chang, J., Li, Y., Mo, S., Chen, Z., Sheng, W., Li, W., & Peng, J. (2026) · European Journal of Cancer · doi:10.1016/j.ejca.2026.117793
Maklad, A. M., & Hakki, R. (2026) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2026.22.2.2
Metadata
- Authors
- Tie, J., Cohen, J. D., Wang, Y., Christie, M., Simons, K., Lee, M., Wong, R., Kosmider, S., Ananda, S., McKendrick, J., Lee, B., Cho, J. H., Faragher, I., Jones, I. T., Ptak, J., Schaeffer, M. J., Silliman, N., Dobbyn, L., Li, L., Tomasetti, C., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., & Gibbs, P.
- Affiliations
- The University of Melbourne (AU)
- Johns Hopkins University (US)
- The Royal Melbourne Hospital (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Western Health (AU)
- Eastern Health (AU)
- Division of Biostatistics & Bioinformatics, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland
- Ludwig Center for Cancer Genetics and Therapeutics, Johns Hopkins University School of Medicine, Baltimore, Maryland
- Corresponding author
- Tie, Jeanne
- ORCID
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2019-12-01
- Volume
- 5
- Issue
- 12
- Pages
- 1710
- ISSN
- 2374-2437 (ISSN-L)
- PMC
- PMC6802034
- OpenAlex
- W2980567593
- Cited by
- 668
- References
- 28
- Citations by year
- 2026: 76 · 2025: 91 · 2024: 104 · 2023: 124 · 2022: 107 · 2021: 102 · 2020: 57 · 2019: 6
- FWCI
- 21.84
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P50CA062924)
- National Institute of General Medical Sciences (T32GM136577)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- circulating tumor DNA, stage III colon cancer, adjuvant chemotherapy, recurrence risk, minimal residual disease, recurrence-free interval, somatic mutations, liquid biopsy, predictive biomarkers, treatment response monitoring, recurrent colorectal cancer, recurrence-free survival, prognostic factors
- MeSH terms
- Circulating Tumor DNA, Adult, Aged, Aged, 80 and over, Australia, Colonic Neoplasms, Female, Humans, Male, Middle Aged, Mutation, Neoplasm Staging, Prognosis, Risk Factors, Biomarkers, Tumor, Treatment Outcome, Chemotherapy, Adjuvant, Neoplasm, Residual, Disease-Free Survival, Precision Medicine, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
